Ziagen
Formulated to target HIV infection to support immune system health in combination with other treatments.
Strengths: 300mg
Where to Check Availability
Medicine details
- Conditions
- Therapeutic class
Nucleoside Reverse Transcriptase Inhibitor (NRTI)
- Pharmacological class
NRTI
- Contraindications
hypersensitivity to abacavir; hepatic impairment
- Minor side effects
nausea; headache; fatigue
- Moderate side effects
diarrhoea; fever; rash
- Dosage forms
Film-coated tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
ViiV Healthcare
- Onset Time
n/a
- Duration
n/a
- Storage instructions
Store at room temperature.
- Drug interactions
Alcohol; Methadone
- Age restrictions
Use requires medical supervision.
- Pregnancy and breastfeeding
Discuss risks with your healthcare provider.
Precautions and warnings
monitor for hypersensitivity reactions; genetic testing for HLA-B*5701 recommended
Serious side effects
hypersensitivity reaction — requires immediate medical attention; lactic acidosis — requires immediate medical attention
Patient summary
Formulated to target HIV infection to support immune system health in combination with other treatments.
Mechanism of action
Abacavir is a nucleoside analogue reverse transcriptase inhibitor that prevents viral replication within host cells.
Ziagen
Formulated to target HIV infection to support immune system health in combination with other treatments.
Editorial Notes
- Active ingredient(s): Abacavir
- Listed indication(s): HIV Infection
Available option
- 30 tablets - 300 mg788-300-mg-17993